These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 28294381

  • 1. CD3+ CD8+ NKG2D+ T Lymphocytes Induce Apoptosis and Necroptosis in HLA-Negative Cells via FasL-Fas Interaction.
    Ivanova OK, Sharapova TN, Romanova EA, Soshnikova NV, Sashchenko LP, Yashin DV.
    J Cell Biochem; 2017 Oct; 118(10):3359-3366. PubMed ID: 28294381
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FasL and the NKG2D receptor are required for the secretion of the Tag7/PGRP-S-Hsp70 complex by the cytotoxic CD8+ lymphocytes.
    Sashchenko LP, Romanova EA, Ivanova OK, Sharapova TN, Yashin DV.
    IUBMB Life; 2017 Jan; 69(1):30-36. PubMed ID: 27868339
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic T lymphocytes carrying a pattern recognition protein Tag7 can detect evasive, HLA-negative but Hsp70-exposing tumor cells, thereby ensuring FasL/Fas-mediated contact killing.
    Sashchenko LP, Dukhanina EA, Shatalov YV, Yashin DV, Lukyanova TI, Kabanova OD, Romanova EA, Khaidukov SV, Galkin AV, Gnuchev NV, Georgiev GP.
    Blood; 2007 Sep 15; 110(6):1997-2004. PubMed ID: 17551095
    [Abstract] [Full Text] [Related]

  • 5. Innate Immunity Protein Tag7 Induces 3 Distinct Populations of Cytotoxic Cells That Use Different Mechanisms to Exhibit Their Antitumor Activity on Human Leukocyte Antigen-Deficient Cancer Cells.
    Sharapova TN, Ivanova OK, Soshnikova NV, Romanova EA, Sashchenko LP, Yashin DV.
    J Innate Immun; 2017 Sep 15; 9(6):598-608. PubMed ID: 28977785
    [Abstract] [Full Text] [Related]

  • 6. FasL on the surface of Tag7 (PGRP-S)-activated lymphocytes induces necroptosis in HLA-negative tumor cells with the involvement of lysosomes and mitochondria.
    Sharapova TN, Romanova EA, Sashchenko LP, Yashin DV.
    Biochimie; 2018 Sep 15; 152():174-180. PubMed ID: 30103900
    [Abstract] [Full Text] [Related]

  • 7. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway.
    Tateyama M, Oyaizu N, McCloskey TW, Than S, Pahwa S.
    Blood; 2000 Jul 01; 96(1):195-202. PubMed ID: 10891451
    [Abstract] [Full Text] [Related]

  • 8. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients.
    Guo CL, Yang XH, Cheng W, Xu Y, Li JB, Sun YX, Bi YM, Zhang L, Wang QC.
    Asian Pac J Cancer Prev; 2014 Jul 01; 15(6):2613-8. PubMed ID: 24761872
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tilorone activates NK cells and cytotoxic lymphocytes that kill HLA-negative tumor cells.
    Sharapova TN, Romanova EA, Sashchenko LP, Yashin DV.
    IUBMB Life; 2019 Mar 01; 71(3):376-384. PubMed ID: 30537230
    [Abstract] [Full Text] [Related]

  • 12. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F, Contini P, Ghio M, Indiveri F.
    ScientificWorldJournal; 2002 Feb 12; 2():421-3. PubMed ID: 12806026
    [Abstract] [Full Text] [Related]

  • 13. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT, Dinglasan RD, Krishnamurthy B, Gullo CA, Graham MB, Braciale VL.
    J Immunol; 1997 Jun 15; 158(12):5612-8. PubMed ID: 9190908
    [Abstract] [Full Text] [Related]

  • 14. Killing of Latently HIV-Infected CD4 T Cells by Autologous CD8 T Cells Is Modulated by Nef.
    Sevilya Z, Chorin E, Gal-Garber O, Zelinger E, Turner D, Avidor B, Berke G, Hassin D.
    Front Immunol; 2018 Jun 15; 9():2068. PubMed ID: 30254642
    [Abstract] [Full Text] [Related]

  • 15. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L, Radrizzani M, Accornero P, Squarcina P, Chiodoni C, Mazzocchi A, Castelli C, Tarsini P, Viggiano V, Belli F, Colombo MP, Parmiani G.
    J Immunol; 1998 Aug 01; 161(3):1220-30. PubMed ID: 9686582
    [Abstract] [Full Text] [Related]

  • 16. HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.
    Truman JP, Choqueux C, Tschopp J, Vedrenne J, Le Deist F, Charron D, Mooney N.
    Blood; 1997 Mar 15; 89(6):1996-2007. PubMed ID: 9058721
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S, Zhang X, Mann KK, Jodo S, Li L, Jarjour WN, Marshak-Rothstein A, Sherr DH, Ju ST.
    Int Immunol; 2004 May 15; 16(5):759-66. PubMed ID: 15096479
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.